Status:

COMPLETED

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

Lead Sponsor:

Northwestern University

Conditions:

Spinal Cord Injury

Bone Loss

Eligibility:

All Genders

21+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine if a year of alendronate treatment will maintain or increase bone mass density (BMD) compared to baseline BMD values in people with chronic spinal cord injury...

Detailed Description

This extension study will enroll individuals who have completed treatment in the parent protocol "Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Sp...

Eligibility Criteria

Inclusion

  • Prior enrollment in protocol "Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury", (NCT01225055).
  • Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 90 days following completion of therapy.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion

  • Individual with renal insufficiency (calculated creatinine clearance \< 30 ml/min).
  • Individuals who are not able to sit or stand upright for at least 30 minutes after taking their medication.
  • Individuals with poor dental hygiene.
  • Individuals with esophageal abnormalities.
  • Individuals who are not able to tolerate alendronate treatment.
  • Individuals who will not be able to return for all study visits.
  • Patients may not be receiving any other investigational agents.
  • Other medical conditions that in the opinion of the investigator would preclude the subject from completing the study

Key Trial Info

Start Date :

April 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 5 2016

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT02195895

Start Date

April 1 2014

End Date

August 5 2016

Last Update

March 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University Feinberg School of Medicine

Chicago, Illinois, United States, 60611